Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer

By Lamond Nathan   Skedgel Chris   Rayson Daniel   Lethbridge Lynn   Younis Tallal  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1115-1123

Springer Publishing Company

Access to resources Recommend Favorite

Occult Lymph Node Metastases Detected by Cytokeratin Immunohistochemistry Predict Recurrence in Node-Negative Endometrial Cancer

By Yabushita H.   Shimazu M.   Yamada H.   Sawaguchi K.   Noguchi M.   Nakanishi M.   Kawai M.  

Gynecologic Oncology, Vol. 80, Iss. 2, 2001-02 ,pp. : 139-144

Elsevier

Access to resources Recommend Favorite

The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use

By Eiermann W.   Rezai M.   Kmmel S.   Khn T.   Warm M.   Friedrichs K.   Schneeweiss A.   Markmann S.   Eggemann H.   Hilfrich J.   Jackisch C.   Witzel I.   Eidtmann H.   Bachinger A.   Hell S.   Blohmer J.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 618-624

Oxford University Press

Access to resources Recommend Favorite

Inflammatory cells in node-negative breast cancer

By Löfdahl Britta   Ahlin Cecilia   Holmqvist Marit   Holmberg Lars   Zhou Wenjing   Fjällskog Marie-Louise   Amini Rose-Marie  

Acta Oncologica, Vol. 51, Iss. 5, 2012-05 ,pp. : 680-686

Informa Healthcare

Access to resources Recommend Favorite

Malignant Endometrial Polyps in Postmenopausal Breast Cancer Tamoxifen-Treated Patients

By Cohen I.   Bernheim J.   Azaria R.   Tepper R.   Sharony R.   Beyth Y.  

Gynecologic Oncology, Vol. 75, Iss. 1, 1999-10 ,pp. : 136-141

Elsevier

Access to resources Recommend Favorite